Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease

Intern Med. 2024 Jun 1;63(11):1563-1568. doi: 10.2169/internalmedicine.2489-23. Epub 2023 Oct 13.

Abstract

We herein report a rare case of idiopathic portal hypertension (IPH)-like disease that developed after allogeneic hematopoietic stem cell transplantation (allo-HSCT). A 53-year-old woman who underwent allo-HSCT for acute myeloid leukemia showed portal hypertension with radiological and histopathological findings consistent with IPH, distinct from veno-occlusive disease (VOD) and graft-versus-host disease (GVHD) of the liver. This case highlights the importance of considering IPH-like disease as a potential cause of portal hypertension after allo-HSCT. Awareness of this complication can aid in the early diagnosis and appropriate management of patients post allo-HSCT.

Keywords: allogeneic hematopoietic stem cell transplantation; esophageal varices; graft-versus-host disease; idiopathic portal hypertension; veno-occlusive disease.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Graft vs Host Disease* / complications
  • Graft vs Host Disease* / etiology
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Hepatic Veno-Occlusive Disease* / diagnosis
  • Hepatic Veno-Occlusive Disease* / diagnostic imaging
  • Hepatic Veno-Occlusive Disease* / etiology
  • Humans
  • Hypertension, Portal* / diagnosis
  • Hypertension, Portal* / etiology
  • Leukemia, Myeloid, Acute / complications
  • Leukemia, Myeloid, Acute / therapy
  • Liver Cirrhosis / complications
  • Middle Aged
  • Transplantation, Homologous / adverse effects